Optecure +Ccc
Filler, Bone Void, Osteoinduction (W/O Human Growth Factor). 510(k) K061668, from Exactech, Inc. (Gainesville, FL). Product code MBP, class 2.
As of Nov 18, 2026, K061668 is an FDA 510(k) held by Exactech, Inc., substantially equivalent on Sep 12, 2006 after 90 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: Sep 12, 2006
- Review time: 90 days
- Recalls: 0
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFOpteCure + CCC is intended for use as a bone graft extender (extremities, spine and pelvis) and as a bone void filler (extremities and pelvis) for bony voids or gaps of the skeletal system that are not intrinsic to the stability of the bony structure. These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- OptecureK050806 · Exactech, Inc. · Feb 8, 2006
- Opteform, Osteofil, Rti Allograft Paste Ic, Rti Allograft Strip IcK043421 · Regeneration Technologies, Inc. · Feb 16, 2005
- Grafton DbmK051195 · Osteotech, Inc. · Dec 16, 2005
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- Optecure Bone Void Filler (0.5 Cc, 1CC, 2CC, 5CC, 10CC, And 20CC), Optecure + Ccc Bone Void Filler (1CC, 2CC, 5CC, 10CC,K121989 · Exactech, Inc. · Nov 27, 2012
Other MBP Clearances
The newest 510(k)s for the same product code; see every MBP device- PliaFX FloK242799 · Lifenet Health · Nov 21, 2024
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 14, 2006
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3045
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files